My Biotech Life

Tomorrow, Thursday 8th of March, Mike Bristow (M.D., PhD) will be interviewed via LIVE broadcast over at Colorado Life Science Deal Flow where he will be speaking about the founding and development of Myogen.

Dr. Bristow was the principal founder, chief science & medical officer and director of Myogen. In November of 2006 Gilead acquired Myogen for $52.50/share or a whopping $2.5 billion! Dr. Bristow is Professor of Medicine and the former Head of Cardiology, University of Colorado Health Sciences Center, the Co-Director of the Colorado Cardiovascular Institute and is presently founder, chair and CSMO of ARCA Discovery.

If you are interested, tune in at Colorado Life Science Deal Flow between 8:00 & 9:00am MST on Thursday 8 March to catch the LIVE broadcast.

[Image: w3w3.com]

Hat tip: Colorado Life Science Deal Flow

• Mendeley goes public and gets some love from ex-Skype and last.fm
• Pharma and Biotech updates at PharmaTelevision
• Bio::Blogs #14 almost here
• Biotech community in Toronto
• Keeping up with the Tbx transcription factors